Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis

Hypoglycemia as a potential risk for patients taking clopidogrel: A systematic review and meta-analysis

BackgroundClopidogrel is a cornerstone antiplatelet drug used in cardiovascular, cerebrovascular, and peripheral artery diseases. The sulfhydryl group of clopidogrel metabolite could induce insulin autoimmune syndrome (IAS) with hypoglycemia as the major symptom. Discontinuing clopidogrel and substi...

Full description

Bibliographic Details
Main Authors: Shi Chen, Jiaqi Qiang, Yuelun Zhang, Bin Zhao, Ran Tian, Tao Yuan, Ming Li, Mei Li, Yuxiu Li, Huijuan Zhu, Hui Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Endocrinology
Subjects:
clopidogrel
hypoglycemia
insulin autoimmune syndrome
meta-analysis
adverse event
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1091933/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1091933/full

Similar Items